Deep Genomics

AI platform for discovering RNA-targeted therapeutics from genetic variants

AI Healthcare & MedicalPaid

Deep Genomics is an AI therapeutics company that uses deep learning to understand how genetic mutations affect RNA processing and then identify RNA-targeted medicines to correct those effects. Its platform, trained on genomic data and RNA biology, can predict the impact of any genetic variant on splicing and gene expression, enabling systematic discovery of oligonucleotide drug candidates. The company has used this AI-first approach to advance multiple drug candidates into its own pipeline and offers partnership capabilities for external programs. Pharmaceutical companies seeking AI-guided RNA therapeutic discovery and researchers studying genetic disease mechanisms use Deep Genomics' platform.

Key Features

• ✓RNA targeting
• ✓Variant impact prediction
• ✓Splicing analysis
• ✓Drug candidate ID
• ✓Oligonucleotide design